RhumbLine Advisers’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $498K | Buy |
102,169
+62,747
| +159% | +$306K | ﹤0.01% | 2687 |
|
2025
Q1 | $146K | Sell |
39,422
-4,255
| -10% | -$15.7K | ﹤0.01% | 3268 |
|
2024
Q4 | $175K | Buy |
43,677
+4,161
| +11% | +$16.6K | ﹤0.01% | 3263 |
|
2024
Q3 | $275K | Buy |
39,516
+5,743
| +17% | +$40K | ﹤0.01% | 3069 |
|
2024
Q2 | $191K | Buy |
+33,773
| New | +$191K | ﹤0.01% | 3244 |
|
2024
Q1 | – | Hold |
0
| – | -$6 | – | 4247 |
|
2023
Q4 | – | Hold |
0
| – | -$2 | – | 4265 |
|
2023
Q3 | – | Sell |
-27
| Closed | -$146 | – | 4305 |
|
2023
Q2 | $146 | Buy |
+27
| New | +$146 | ﹤0.01% | 4363 |
|
2022
Q2 | – | Sell |
-4,777
| Closed | -$86K | – | 3220 |
|
2022
Q1 | $86K | Sell |
4,777
-483
| -9% | -$8.7K | ﹤0.01% | 2914 |
|
2021
Q4 | $138K | Buy |
5,260
+286
| +6% | +$7.5K | ﹤0.01% | 2901 |
|
2021
Q3 | $178K | Buy |
4,974
+112
| +2% | +$4.01K | ﹤0.01% | 2926 |
|
2021
Q2 | $267K | Buy |
4,862
+2,525
| +108% | +$139K | ﹤0.01% | 2829 |
|
2021
Q1 | $194K | Buy |
2,337
+4
| +0.2% | +$332 | ﹤0.01% | 2839 |
|
2020
Q4 | $265K | Buy |
2,333
+444
| +24% | +$50.4K | ﹤0.01% | 2719 |
|
2020
Q3 | $58K | Sell |
1,889
-470
| -20% | -$14.4K | ﹤0.01% | 2939 |
|
2020
Q2 | $104K | Buy |
2,359
+582
| +33% | +$25.7K | ﹤0.01% | 2961 |
|
2020
Q1 | $64K | Buy |
1,777
+50
| +3% | +$1.8K | ﹤0.01% | 2839 |
|
2019
Q4 | $115K | Buy |
1,727
+138
| +9% | +$9.19K | ﹤0.01% | 2862 |
|
2019
Q3 | $247K | Buy |
1,589
+272
| +21% | +$42.3K | ﹤0.01% | 2667 |
|
2019
Q2 | $114K | Buy |
1,317
+304
| +30% | +$26.3K | ﹤0.01% | 2909 |
|
2019
Q1 | $140K | Sell |
1,013
-30
| -3% | -$4.15K | ﹤0.01% | 2813 |
|
2018
Q4 | $419K | Buy |
1,043
+382
| +58% | +$153K | ﹤0.01% | 2380 |
|
2018
Q3 | $468K | Buy |
661
+89
| +16% | +$63K | ﹤0.01% | 2306 |
|
2018
Q2 | $306K | Buy |
+572
| New | +$306K | ﹤0.01% | 2522 |
|